These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27720930)

  • 1. Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery.
    Marques J; Valle-Delgado JJ; Urbán P; Baró E; Prohens R; Mayor A; Cisteró P; Delves M; Sinden RE; Grandfils C; de Paz JL; García-Salcedo JA; Fernàndez-Busquets X
    Nanomedicine; 2017 Feb; 13(2):515-525. PubMed ID: 27720930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells in vitro.
    Urbán P; Estelrich J; Cortés A; Fernàndez-Busquets X
    J Control Release; 2011 Apr; 151(2):202-11. PubMed ID: 21223986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoliposome-mediated drug delivery to Plasmodium-infected and non-infected red blood cells as a dual therapeutic/prophylactic antimalarial strategy.
    Moles E; Urbán P; Jiménez-Díaz MB; Viera-Morilla S; Angulo-Barturen I; Busquets MA; Fernàndez-Busquets X
    J Control Release; 2015 Jul; 210():217-29. PubMed ID: 26008752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyamidoamine nanoparticles as nanocarriers for the drug delivery to malaria parasite stages in the mosquito vector.
    Urbán P; Ranucci E; Fernàndez-Busquets X
    Nanomedicine (Lond); 2015 Nov; 10(22):3401-14. PubMed ID: 26582279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugs.
    Movellan J; Urbán P; Moles E; de la Fuente JM; Sierra T; Serrano JL; Fernàndez-Busquets X
    Biomaterials; 2014 Sep; 35(27):7940-50. PubMed ID: 24930847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of heparin as a dual agent with antimalarial and liposome targeting activities toward Plasmodium-infected red blood cells.
    Marques J; Moles E; Urbán P; Prohens R; Busquets MA; Sevrin C; Grandfils C; Fernàndez-Busquets X
    Nanomedicine; 2014 Nov; 10(8):1719-28. PubMed ID: 24941466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium.
    Urbán P; Valle-Delgado JJ; Mauro N; Marques J; Manfredi A; Rottmann M; Ranucci E; Ferruti P; Fernàndez-Busquets X
    J Control Release; 2014 Mar; 177():84-95. PubMed ID: 24412735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine against malaria.
    Urbán P; Fernàndez-Busquets X
    Curr Med Chem; 2014; 21(5):605-29. PubMed ID: 24164202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model.
    Moles E; Galiano S; Gomes A; Quiliano M; Teixeira C; Aldana I; Gomes P; Fernàndez-Busquets X
    Biomaterials; 2017 Nov; 145():178-191. PubMed ID: 28869864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology applied to the treatment of malaria.
    Santos-Magalhães NS; Mosqueira VC
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):560-75. PubMed ID: 19914313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial Activity of Orally Administered Curcumin Incorporated in Eudragit
    Martí Coma-Cros E; Biosca A; Lantero E; Manca ML; Caddeo C; Gutiérrez L; Ramírez M; Borgheti-Cardoso LN; Manconi M; Fernàndez-Busquets X
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles derived from Plasmodium-infected and non-infected red blood cells as targeted drug delivery vehicles.
    Borgheti-Cardoso LN; Kooijmans SAA; Chamorro LG; Biosca A; Lantero E; Ramírez M; Avalos-Padilla Y; Crespo I; Fernández I; Fernandez-Becerra C; Del Portillo HA; Fernàndez-Busquets X
    Int J Pharm; 2020 Sep; 587():119627. PubMed ID: 32653596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of drug-loaded immunoliposomes for the selective targeting and elimination of rosetting Plasmodium falciparum-infected red blood cells.
    Moles E; Moll K; Ch'ng JH; Parini P; Wahlgren M; Fernàndez-Busquets X
    J Control Release; 2016 Nov; 241():57-67. PubMed ID: 27620073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in use of silver nanoparticles as antimalarial agents.
    Rai M; Ingle AP; Paralikar P; Gupta I; Medici S; Santos CA
    Int J Pharm; 2017 Jun; 526(1-2):254-270. PubMed ID: 28450172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin: new life for an old drug.
    Aláez-Versón CR; Lantero E; Fernàndez-Busquets X
    Nanomedicine (Lond); 2017 Jul; 12(14):1727-1744. PubMed ID: 28635544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in nanomedicines for malaria treatment.
    Aditya NP; Vathsala PG; Vieira V; Murthy RS; Souto EB
    Adv Colloid Interface Sci; 2013 Dec; 201-202():1-17. PubMed ID: 24192063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toy kit against malaria: magic bullets, LEGO, Trojan horses and Russian dolls.
    Fernàndez-Busquets X
    Ther Deliv; 2014 Oct; 5(10):1049-52. PubMed ID: 25418263
    [No Abstract]   [Full Text] [Related]  

  • 19. Promising nanomaterials in the fight against malaria.
    Neves Borgheti-Cardoso L; San Anselmo M; Lantero E; Lancelot A; Serrano JL; Hernández-Ainsa S; Fernàndez-Busquets X; Sierra T
    J Mater Chem B; 2020 Oct; 8(41):9428-9448. PubMed ID: 32955067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-functionalized nanocapsules: enabling targeted delivery of antimalarial drugs.
    Fernàndez-Busquets X
    Future Med Chem; 2013 May; 5(7):737-9. PubMed ID: 23651087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.